C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2004
12/02/2004	CA2524950A1 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid
12/02/2004	CA2524130A1 Ranbp2 as modifier of the pten/igf pathway and methods of use
12/02/2004	CA2523789A1 Genes encoding carotenoid compounds
12/02/2004	CA2431080A1 Enhancement of anticancer immunity through inhibition of arginase
12/02/2004	CA2429891A1 Membrane fusion protein
12/01/2004	EP1482053A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/01/2004	EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1482031A1 Serum-free mammalian cell culture medium, and uses thereof
12/01/2004	EP1482030A1 Method for increasing the yield of proliferating primary keratinocytes
12/01/2004	EP1481992A2 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1481084A2 The use of ribozymes in the detection of adventitious agents
12/01/2004	EP1481069A2 Lis promoter for expression of transgenes in floral tissues
12/01/2004	EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
12/01/2004	EP1481065A2 Method for detection of leptin receptor ligands
12/01/2004	EP1481063A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
12/01/2004	EP1481059A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/01/2004	EP1481055A1 Method for the treatment of diseased, degenerated, or damaged tissue using three-dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors
12/01/2004	EP1481054A2 Il-10 gene transfer to peripheral mononuclear cells
12/01/2004	EP1481010A2 Anti-interleukin-1 beta analogs
12/01/2004	EP1481009A2 Peptides for use in antitumor immunotherapy
12/01/2004	EP1481008A2 Anti-amyloid beta antibodies and their use
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1480993A2 Desaturase genes, enzymes encoded thereby, and uses thereof
12/01/2004	EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
12/01/2004	EP1480665A2 Peptides for recognition and targeting of glial cell tumors
12/01/2004	EP1480660A2 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/01/2004	EP1480520A2 Human fetal bladder-derived epithelial cells
12/01/2004	EP1480519A1 Re-activated t-cells for adoptive immunotherapy
12/01/2004	EP1480515A2 Inbred embryonic stem-cell derived mice
12/01/2004	EP1480514A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
12/01/2004	EP1439861A4 Methods and kits for use in selecting approaches to treating cancer
12/01/2004	EP1435787A4 Nestin-expressing hair follicle stem cells
12/01/2004	EP1379139A4 The use of ecm degrading enzymes for the improvement of cell transplantation
12/01/2004	EP1257584B9 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1156037B1 Chondrongenesis promotors and indolin-2-one derivatives
12/01/2004	EP1121449A4 Delivery system for porcine somatotropin
12/01/2004	EP0912611B9 Human monoclonal antibodies to the hepatitis b surface antigen
12/01/2004	EP0720650B1 Human metabotropic glutamate receptor subtype hmglur7 and related dna compounds
12/01/2004	EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
12/01/2004	CN1551921A Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551914A FAD4, FAD5, FAD5-2 and FAD6, novel fatty acid desaturase family members and uses thereof
12/01/2004	CN1551779A Osteogenis oligopeptide as blood-formation stimulation articles
12/01/2004	CN1551728A Production of transduced hematopoietic progenitor cells
12/01/2004	CN1551726A Hair follicle-reconstitution system and animal carrying the same
12/01/2004	CN1550550A Oncogene, recombinant protein derived therefrom, and uses thereof
12/01/2004	CN1550547A Embryogenic culture initiation of douglas-fir by maltose
12/01/2004	CN1177936C Assessment of intracellular cysteine ad glutathione concentrations
12/01/2004	CN1177933C Chrysosporium cellulase and methods of use
12/01/2004	CN1177932C Method for producing biotin
12/01/2004	CN1177925C Fermenting culture process of producing cordyceps extract
12/01/2004	CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
12/01/2004	CN1177615C Arteriovenous and venous graft treatment methods and compsns.
11/2004
11/30/2004	US6825399 Nucleotide sequences coding enzymatic polypeptide for use in generating poison resistant plants
11/30/2004	US6825394 For in vitro analysis of differentiated epithelial/neuronal cells; bioassays
11/30/2004	US6825332 Gene related to migraine in man
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825325 Fusion proteins; membrane anchoring; genetic engineering; kits
11/30/2004	US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004	US6825322 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/30/2004	US6825164 Method to increase cerebral blood flow in amyloid angiopathy
11/30/2004	US6825036 Genetically engineered cells for use as tool in the generation of vaccines
11/30/2004	US6825035 For drug screening; gene knockout; genetic engineering
11/30/2004	US6825031 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance
11/30/2004	US6825026 Nucleic acids; genetic engineering; culture product
11/30/2004	US6825023 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
11/30/2004	US6825011 For cloning/dna libraries; concatemers; polymerase chain reaction (pcr); fusion proteins
11/30/2004	US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6825005 Methods and reagents to regulate apoptosis
11/30/2004	US6824989 Screening/detection of disease for diagnosis/research; genetic engineering; electrophoresis
11/30/2004	US6824983 Method for the mutagenesis of nucleotide sequences in plants algae or fungi
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824973 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
11/30/2004	US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004	US6824781 Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist
11/30/2004	US6824773 TWEAK receptor
11/30/2004	US6824561 Implantable system with drug-eluting cells for on-demand local drug delivery
11/30/2004	CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/25/2004	WO2004101808A2 Genomic and proteomic approaches for the development of cell culture medium
11/25/2004	WO2004101801A2 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding generic tools, as well as the applications of these non-pathogenic amplicons vectors
11/25/2004	WO2004101776A2 Novel uses of ppar modulators and professional apcs manipulated by the same
11/25/2004	WO2004101775A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	WO2004101774A1 Cell culture method and cultured tissue
11/25/2004	WO2004101773A1 Artificial immune organ
11/25/2004	WO2004101772A2 Neural cells
11/25/2004	WO2004101771A1 Method for selecting cardiomyogenic cells or cardiac muscle cells in mixed cell populations
11/25/2004	WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004	WO2004101758A2 Composition for maintaining organ and cell viability
11/25/2004	WO2004101750A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
11/25/2004	WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004	WO2004101743A2 Three dimensional cell cultures in a microscale fluid handling system
11/25/2004	WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004	WO2004101735A2 Method and device for culturing tissue
11/25/2004	WO2004100870A2 Compositions and methods for wt1 specific immunotherapy

1 ... 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 ... 1827